Light Line Medical is Changing the Way the World Prevents Infection

Fact: Visible light is not antimicrobial-resistant, the third leading cause of death worldwide.

In the U.S., annual hospital-acquired infections (HAI) arising from catheter use cause 100,000 deaths, cost $28-48B, are not reimbursable, and have staggering penalties of over $400M. Antibiotic-resistant pathogens have led to diminishing treatment effectiveness, contributing to one of the world’s most pressing public health threats. Light Line’s platform visible light PhotoDisinfection™ technology (System) prevents infections arising from dialysis, urinary, respiratory, and vascular catheters, and has no antibiotic resistance.

Without relying on drugs, chemicals, or harmful UV light, Light Line’s System uses 405nm visible light (i.e., violet/blue light that the naked eye can see) to prevent infections. The light is emitted through a fiber optic cable placed inside the catheter. This disinfects and protects the inside and outside of catheters, killing microbes.

Light Line’s visible light technology is addressing invasive catheter infections - one of the leading causes of patient morbidity. Infections are life-threatening and difficult to treat, particularly with refractory drug-resistant microbes. In addition to the patient impact, treatment and penalties associated with catheter infections are a significant source of hospital costs.

Light Line Medical, Inc. Videos

Light Line Peritoneal Dialysis PhotoDisinfection System - Video